MAPK8 and lung cancer: MiR-196b must be significantly decreased in lung cancer to maintain tumor cell viability, migration, and invasion and EMT induction by TGF-β, PI3K/AKT/GSK3β, Smad, and JNK pathways, as Runx2 is a putative target of miR-196b [77].